Avadel Pharmaceuticals Plc (AVDL)
21.64
0.00 (0.00%)
USD |
NASDAQ |
Sep 02, 16:00
Avadel Pharmaceuticals Cash from Investing (Quarterly) : -8.788M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | -8.788M |
| June 30, 2025 | -8.100M |
| March 31, 2025 | 12.32M |
| December 31, 2024 | 13.80M |
| September 30, 2024 | 5.443M |
| June 30, 2024 | 10.42M |
| March 31, 2024 | 21.39M |
| December 31, 2023 | 28.72M |
| September 30, 2023 | 9.927M |
| June 30, 2023 | -93.54M |
| March 31, 2023 | 5.066M |
| December 31, 2022 | 23.81M |
| September 30, 2022 | 0.6341M |
| June 30, 2022 | 10.65M |
| March 31, 2022 | 42.25M |
| December 31, 2021 | 14.11M |
| September 30, 2021 | 11.61M |
| June 30, 2021 | 18.14M |
| March 31, 2021 | 11.19M |
| December 31, 2020 | 7.238M |
| September 30, 2020 | -12.50M |
| June 30, 2020 | -80.88M |
| March 31, 2020 | 13.23M |
| December 31, 2019 | 5.136M |
| September 30, 2019 | 2.989M |
| Date | Value |
|---|---|
| June 30, 2019 | 8.790M |
| March 31, 2019 | 21.39M |
| December 31, 2018 | 16.11M |
| September 30, 2018 | 26.12M |
| June 30, 2018 | 2.737M |
| March 31, 2018 | -80.74M |
| December 31, 2017 | -0.2833M |
| September 30, 2017 | 0.4128M |
| June 30, 2017 | 15.47M |
| March 31, 2017 | -31.99M |
| December 31, 2016 | 14.54M |
| September 30, 2016 | 0.4864M |
| June 30, 2016 | -9.723M |
| March 31, 2016 | -40.99M |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | -23.43M |
| December 31, 2014 | 16.49M |
| September 30, 2014 | -32.92M |
| June 30, 2014 | 3.652M |
| March 31, 2014 | -27.79M |
| December 31, 2013 | 1.954M |
| September 30, 2013 | -0.242M |
| June 30, 2013 | -0.1114M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Jazz Pharmaceuticals Plc | 354.90M |
| Perrigo Co. Plc | 349.40M |
| GH Research Plc | 6.295M |
| Cosmo NV | -- |
| Alkermes Plc | -2.411M |